−490 KRW
−4.21 B KRW
91.52 M KRW
9.29 M
About ONCOCROSS CO.,LTD.
Sector
CEO
Yi-Rang Kim
Headquarters
Seoul
Website
Founded
2015
ISIN
KR7382150001
FIGI
BBG01QB23D57
Oncocross Co., Ltd. engages in conducting joint research on new drugs with several domestic and foreign pharmaceutical companies. It provides a new approach to new drug development by sharing the analysis results using AI new drug development platform. The company was founded by Yi-Rang Kim on June 22, 2015 and is headquartered in Seoul, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 382150 is 8,650 KRW — it has increased by 13.94% in the past 24 hours. Watch ONCOCROSS CO.,LTD. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange ONCOCROSS CO.,LTD. stocks are traded under the ticker 382150.
382150 stock has risen by 36.41% compared to the previous week, the month change is a −32.17% fall, over the last year ONCOCROSS CO.,LTD. has showed a −31.62% decrease.
382150 reached its all-time high on Dec 18, 2024 with the price of 14,450 KRW, and its all-time low was 6,260 KRW and was reached on Jan 2, 2025. View more price dynamics on 382150 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track ONCOCROSS CO.,LTD. financials in yearly and quarterly reports right on TradingView.
382150 net income for the last quarter is −1.37 B KRW, while the quarter before that showed −1.36 B KRW of net income which accounts for −0.63% change. Track more ONCOCROSS CO.,LTD. financial stats to get the full picture.
No, 382150 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Jan 7, 2025, the company has 31.00 employees. See our rating of the largest employees — is ONCOCROSS CO.,LTD. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ONCOCROSS CO.,LTD. EBITDA is −6.93 B KRW, and current EBITDA margin is −7.22 K%. See more stats in ONCOCROSS CO.,LTD. financial statements.
Like other stocks, 382150 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ONCOCROSS CO.,LTD. stock right from TradingView charts — choose your broker and connect to your account.